Carregant...
Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
OBJECTIVE: The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) trial demonstrated that combination therapy with metformin plus rosiglitazone provided superior durability of glycemic control compared with metformin alone, with significantly lower treatment failure rates (38.6 v...
Guardat en:
| Format: | Artigo |
|---|---|
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661836/ https://ncbi.nlm.nih.gov/pubmed/23704674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2393 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|